EFPIA Supports Uniform Approach By EU Member States On Remote Batch Certification
Requirement For MIA Holders To Demonstrate Time Spent By QPs On Site Raises Concern
Executive Summary
The European federation of research-based drug companies has made suggestions to ensure the consistent adoption of an EU proposal that seeks to continue the flexibilities that were introduced in response to COVID-19-related travel restrictions.
You may also be interested in...
Batch Testing ‘Could Double’ Under Govt Proposals For Great Britain
The UK government is consulting on a set of options for batch testing of imported medicines as it seeks to balance patient safety principles with the need to avoid overly burdensome import requirements.
EMA Proposes Extending Remote QP Batch Certification Post-Pandemic
Stakeholders given one month to weigh in on proposal to allow relaxations introduced in response to COVID-19-related travel restrictions to continue on a routine basis.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.